軸突生長(zhǎng)誘向因子1(Ntn1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)
ELISA Kit for Netrin 1 (Ntn1)
NTN1L; Epididymis tissue protein Li 131P
- 編號(hào)SEB827Mu
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)3h
- 檢測(cè)范圍15.6-1,000pg/mL
- 靈敏度最小可檢測(cè)劑量小于等于5.6pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價(jià)格 ¥ 2873 ¥ 4104 ¥ 18468 ¥ 34884 ¥ 287280
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
實(shí)驗(yàn)結(jié)果圖
-
標(biāo)準(zhǔn)曲線圖
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
本試劑盒用于檢測(cè)軸突生長(zhǎng)誘向因子1(Ntn1)，經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制，不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè)，因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的軸突生長(zhǎng)誘向因子1(Ntn1)（加標(biāo)樣品），重復(fù)測(cè)定并計(jì)算其均值，回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 84-101 | 88 |
| EDTA plasma(n=5) | 86-101 | 94 |
| heparin plasma(n=5) | 83-93 | 89 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差：取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次，分別計(jì)算不同濃度樣本的平均值及SD值。
批間差：選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定，每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次，分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的軸突生長(zhǎng)誘向因子1(Ntn1)，并倍比稀釋成1:2，1:4，1:8，1:16的待測(cè)樣本，線性范圍即為稀釋后樣本中軸突生長(zhǎng)誘向因子1(Ntn1)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 79-90% | 91-101% | 97-105% | 96-103% |
| EDTA plasma(n=5) | 92-102% | 88-104% | 83-101% | 81-95% |
| heparin plasma(n=5) | 83-90% | 79-97% | 79-91% | 93-104% |
穩(wěn)定性
經(jīng)測(cè)定，試劑盒在有效期內(nèi)按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響，實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致，尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備；
2. 加樣（標(biāo)準(zhǔn)品及樣本）100µL，37°C孵育1小時(shí)；
3. 吸棄，加檢測(cè)溶液A100µL，37°C孵育1小時(shí)；
4. 洗板3次；
5. 加檢測(cè)溶液B100µL，37°C孵育30分鐘；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分鐘；
8. 加終止液50µL，立即450nm讀數(shù)。
實(shí)驗(yàn)原理
將軸突生長(zhǎng)誘向因子1(Ntn1)抗體包被于96孔微孔板中，制成固相載體，向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本，其中的軸突生長(zhǎng)誘向因子1(Ntn1)與連接于固相載體上的抗體結(jié)合，然后加入生物素化的軸突生長(zhǎng)誘向因子1(Ntn1)抗體，將未結(jié)合的生物素化抗體洗凈后，加入HRP標(biāo)記的親和素，再次徹底洗滌后加入TMB底物顯色。TMB在過(guò)氧化物酶的催化下轉(zhuǎn)化成藍(lán)色，并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的軸突生長(zhǎng)誘向因子1(Ntn1)呈正相關(guān)。用酶標(biāo)儀在450nm波長(zhǎng)下測(cè)定吸光度(O.D.值)，計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB827Mu01 | 軸突生長(zhǎng)誘向因子1(Ntn1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB827Mu02 | 軸突生長(zhǎng)誘向因子1(Ntn1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB827Mu01 | 軸突生長(zhǎng)誘向因子1(Ntn1)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB827Mu02 | 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB827Mu01 | 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB827Mu81 | 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB827Mu71 | 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEB827Mu | 軸突生長(zhǎng)誘向因子1(Ntn1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB827Mu | 軸突生長(zhǎng)誘向因子1(Ntn1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Transplantation Proceedings | Netrin-1: A Novel Universal Biomarker of Human Kidney Injury [PubMed: 20620466] |
| Biomarkers | Plasma netrin-1 is a diagnostic biomarker of human cancers [PubMed: PMC3143477] |
| Journal of Maternal-Fetal and Neonatal Medicine | Cord blood netrin-1 and -4 concentrations in term pregnancies with normal, restricted and increased fetal growth [Informahealthcare: Source] |
| 4 | Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity [Pubmed:24584118] |
| J Matern?Fetal?Neonatal Med.? | Cord blood netrin-1 and-4 concentrations in term pregnancies with normal, restricted and increased fetal growth [Pubmed:24716747] |
| Renal failure. | Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury [Pubmed:25154466] |
| Stem Cell Research & Therapy | Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton’s jelly mesenchymal stem cells (WJ-MSC) [articles:10.1186] |
| Oncotarget | The effect of aspirin on circulating netrin-1 levels in humans is dependent on the inflammatory status of the vascular endothelium. [pubmed:29156815] |
| Frontiers in?Cellular?Neuroscience | Neuroprotection Exerted by Netrin-1 and Kinesin Motor KIF1A in Secondary Brain Injury following Experimental Intracerebral Hemorrhage in Rats [Pubmed:29375318] |
| Scientific Reports | Netrin-1 promotes diabetic corneal wound healing through molecular mechanisms mediated via the adenosine 2B receptor [Pubmed:29662125] |
| Family Practice and Palliative Care | Relationship of serum netrin-1 levels with breast masses [Doi: 10.22391/fppc.467700] |
| JOURNAL OF BIOLOGICAL CHEMISTRY | Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity [Pubmed: 30910812] |
| International Journal of Molecular?Sciences | Downregulation of the Netrin-1 Receptor UNC5b Underlies Increased Placental Angiogenesis in Human Gestational Diabetes Mellitus [Pubmed: 30897795] |
| Cancer Biomark | Serum netrin-1 as a biomarker for colorectal cancer detection [Pubmed: 32474463] |
| Níveis Elevados de Netrina-1 e IL-1β em Mulheres Idosas com SCA: Pior Prognóstico no Acompanhamento de Dois Anos [] | |
| Tuberk Toraks | Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD [33853303] |
| Adv Healthc Mater | Conductive Hydrogel Conduits with Growth Factor Gradients for Peripheral Nerve Repair in Diabetics with Non‐suture Tape [Pubmed:35670309] |
